WeVote
Log In

Bill

Bill

HB 1549

RELATING TO CONTROLLED SUBSTANCES.

2026 Regular Session Introduced by Terez Amato and 10 co-sponsors

Hawaii HB 1549 addresses controlled substances policy and is advancing through committee review to determine its public health and criminal justice impacts.

Referred to HLT, JHA, referral sheet 1
#controlledsubstances #drugparaphernalia #repeal
0
WeVote Research Nonpartisan
Bill Summary · HB 1549

Legislative bill overview

HB 1549 is a Hawaii bill relating to controlled substances that was introduced in January 2026 and is currently in the early stages of the legislative process. The bill has passed first reading and is awaiting committee review by the Health (HLT) and Judiciary (JHA) committees. Without access to the full bill text, the specific provisions regarding controlled substances cannot be detailed.

Why is this important

Controlled substance legislation directly affects public health policy, law enforcement priorities, criminal penalties, and healthcare access in Hawaii. Such bills often address drug scheduling, treatment versus incarceration approaches, and medical access to medications, making them consequential for both individuals and communities.

Potential points of contention

  • Unclear scope: The bill's specific provisions are not publicly described yet, making it difficult to identify which substances or policies are affected and who benefits or is burdened
  • Committee jurisdiction: Dual referral to both Health and Judiciary suggests the bill may bridge treatment/public health and criminal justice approaches, potentially creating tension between those frameworks
  • Early stage uncertainty: With only first reading completed, the bill's final language and intent may still evolve significantly through committee amendments

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.